Patient Capital Management, LLC Precigen, Inc. Transaction History
Patient Capital Management, LLC
- $1.75 Billion
- Q1 2025
A detailed history of Patient Capital Management, LLC transactions in Precigen, Inc. stock. As of the latest transaction made, Patient Capital Management, LLC holds 17,372,301 shares of PGEN stock, worth $23.3 Million. This represents 1.48% of its overall portfolio holdings.
Number of Shares
17,372,301
Previous 17,881,246
2.85%
Holding current value
$23.3 Million
Previous $20 Million
29.25%
% of portfolio
1.48%
Previous 1.03%
Shares
11 transactions
Others Institutions Holding PGEN
# of Institutions
153Shares Held
164MCall Options Held
1.11MPut Options Held
36.8K-
Third Security, LLC83.5MShares$112 Million73.5% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA11.3MShares$15.1 Million0.03% of portfolio
-
Black Rock Inc. New York, NY10.2MShares$13.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.8MShares$11.8 Million0.0% of portfolio
-
Iridian Asset Management LLC4.59MShares$6.14 Million2.25% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $279M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...